441 related articles for article (PubMed ID: 21843648)
1. Antibody drug conjugates - Trojan horses in the war on cancer.
Iyer U; Kadambi VJ
J Pharmacol Toxicol Methods; 2011; 64(3):207-12. PubMed ID: 21843648
[TBL] [Abstract][Full Text] [Related]
2. Antibody-drug conjugates: current status and future directions.
Perez HL; Cardarelli PM; Deshpande S; Gangwar S; Schroeder GM; Vite GD; Borzilleri RM
Drug Discov Today; 2014 Jul; 19(7):869-81. PubMed ID: 24239727
[TBL] [Abstract][Full Text] [Related]
3. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
4. Challenges in the development and manufacturing of antibody-drug conjugates.
Ducry L
Methods Mol Biol; 2012; 899():489-97. PubMed ID: 22735971
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody-based therapies in cancer: advances and challenges.
Sapra P; Shor B
Pharmacol Ther; 2013 Jun; 138(3):452-69. PubMed ID: 23507041
[TBL] [Abstract][Full Text] [Related]
6. Antibody-drug conjugates for cancer therapy.
Carter PJ; Senter PD
Cancer J; 2008; 14(3):154-69. PubMed ID: 18536555
[TBL] [Abstract][Full Text] [Related]
7. The next generation of antibody drug conjugates.
Mack F; Ritchie M; Sapra P
Semin Oncol; 2014 Oct; 41(5):637-52. PubMed ID: 25440608
[TBL] [Abstract][Full Text] [Related]
8. Antibody drug conjugates: the future of chemotherapy?
Borcoman E; Le Tourneau C
Curr Opin Oncol; 2016 Sep; 28(5):429-36. PubMed ID: 27366963
[TBL] [Abstract][Full Text] [Related]
9. Antibody-Drug Conjugates for Cancer Therapy.
Hafeez U; Parakh S; Gan HK; Scott AM
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081383
[TBL] [Abstract][Full Text] [Related]
10. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
Yamada K; Ito Y
Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
[TBL] [Abstract][Full Text] [Related]
11. Antibody drug conjugates.
Bakhtiar R
Biotechnol Lett; 2016 Oct; 38(10):1655-64. PubMed ID: 27334710
[TBL] [Abstract][Full Text] [Related]
12. Antibody-drug conjugates as novel anti-cancer chemotherapeutics.
Peters C; Brown S
Biosci Rep; 2015 Jun; 35(4):. PubMed ID: 26182432
[TBL] [Abstract][Full Text] [Related]
13. Antibody-cytotoxic agent conjugates for cancer therapy.
Chen J; Jaracz S; Zhao X; Chen S; Ojima I
Expert Opin Drug Deliv; 2005 Sep; 2(5):873-90. PubMed ID: 16296784
[TBL] [Abstract][Full Text] [Related]
14. Toward an effective targeted chemotherapy for multiple myeloma.
Polson AG; Sliwkowski MX
Clin Cancer Res; 2009 Jun; 15(12):3906-7. PubMed ID: 19509145
[TBL] [Abstract][Full Text] [Related]
15. Antibody-targeted drugs and drug resistance--challenges and solutions.
Shefet-Carasso L; Benhar I
Drug Resist Updat; 2015 Jan; 18():36-46. PubMed ID: 25476546
[TBL] [Abstract][Full Text] [Related]
16. Antibody targeted drugs as cancer therapeutics.
Schrama D; Reisfeld RA; Becker JC
Nat Rev Drug Discov; 2006 Feb; 5(2):147-59. PubMed ID: 16424916
[TBL] [Abstract][Full Text] [Related]
17. Antibody-drug conjugates as targeted cancer therapeutics.
Sun Y; Yu F; Sun BW
Yao Xue Xue Bao; 2009 Sep; 44(9):943-52. PubMed ID: 20055167
[TBL] [Abstract][Full Text] [Related]
18. [Design of next generation antibody drug conjugates].
Zhu GD; Fu YX
Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
[TBL] [Abstract][Full Text] [Related]
19. Antibody-drug conjugates: an emerging concept in cancer therapy.
Chari RV; Miller ML; Widdison WC
Angew Chem Int Ed Engl; 2014 Apr; 53(15):3796-827. PubMed ID: 24677743
[TBL] [Abstract][Full Text] [Related]
20. Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.
Vezina HE; Cotreau M; Han TH; Gupta M
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S11-S25. PubMed ID: 28921650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]